IGC PHARMA INC (IGC) Stock Price & Overview
NYSEARCA:IGC • US45408X3089
Current stock price
The current stock price of IGC is 0.2753 USD. Today IGC is down by -3.81%. In the past month the price increased by 3.5%. In the past year, price decreased by -6.36%.
IGC Key Statistics
- Market Cap
- 25.567M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.08
- Dividend Yield
- N/A
IGC Stock Performance
IGC Stock Chart
IGC Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to IGC. When comparing the yearly performance of all stocks, IGC is a bad performer in the overall market: 74.1% of all stocks are doing better.
IGC Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to IGC. IGC has a bad profitability rating. Also its financial health evaluation is rather negative.
IGC Earnings
IGC Forecast & Estimates
5 analysts have analysed IGC and the average price target is 3.7 USD. This implies a price increase of 1243.08% is expected in the next year compared to the current price of 0.2753.
For the next year, analysts expect an EPS growth of 12.09% and a revenue growth 4.61% for IGC
IGC Groups
Sector & Classification
IGC Financial Highlights
Over the last trailing twelve months IGC reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 58.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -66.16% | ||
| ROE | -79.66% | ||
| Debt/Equity | 0.02 |
IGC Ownership
IGC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.05 | 858.976B | ||
| JNJ | JOHNSON & JOHNSON | 20.21 | 567.035B | ||
| MRK | MERCK & CO. INC. | 22.35 | 286.006B | ||
| PFE | PFIZER INC | 8.97 | 152.277B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9 | 116.079B | ||
| ZTS | ZOETIS INC | 16.28 | 48.642B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.83 | 26.311B | ||
| VTRS | VIATRIS INC | 5.3 | 15.302B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.23 | 12.151B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.022B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.67B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.269B | ||
| LGND | LIGAND PHARMACEUTICALS | 23.6 | 3.995B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About IGC
Company Profile
The company is headquartered in Potomac, Maryland and currently employs 70 full-time employees. The company went IPO on 2006-04-13.
Company Info
IPO: 2006-04-13
IGC PHARMA INC
10224 Falls Road
Potomac MARYLAND 20854 US
CEO: Ram Mukunda
Employees: 70
Phone: 13015294996
IGC PHARMA INC / IGC FAQ
What does IGC do?
The company is headquartered in Potomac, Maryland and currently employs 70 full-time employees. The company went IPO on 2006-04-13.
What is the stock price of IGC PHARMA INC today?
The current stock price of IGC is 0.2753 USD. The price decreased by -3.81% in the last trading session.
Does IGC PHARMA INC pay dividends?
IGC does not pay a dividend.
What is the ChartMill technical and fundamental rating of IGC stock?
IGC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is IGC stock listed?
IGC stock is listed on the NYSE Arca exchange.
What do analysts say about IGC PHARMA INC (IGC) stock?
5 analysts have analysed IGC and the average price target is 3.7 USD. This implies a price increase of 1243.08% is expected in the next year compared to the current price of 0.2753.
What is the Price/Earnings (PE) ratio of IGC PHARMA INC (IGC)?
IGC PHARMA INC (IGC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).